Patents by Inventor Guowei Wei

Guowei Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11597774
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, an antibody variable domain or antibody construct, inter alia, useful for targeting and killing cancer cells. Due to their ability to differentially bind cancer cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: March 7, 2023
    Assignees: CITY OF HOPE, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Hong Qin, Larry W. Kwak, Guowei Wei
  • Publication number: 20230027639
    Abstract: A monoclonal antibody used for specifically binding to CAR molecules, which is characterized in that the monoclonal antibody comprises a light chain and a heavy chain, the light chain comprises CDR regions having an amino acid sequence as shown in SEQ ID NO: 1-3, and the heavy chain comprises CDR regions having an amino acid sequence as shown in SEQ ID NO: 5-7. By using the described monoclonal antibody or a CAR-T cell detection kit, the steps of CAR-T cell detection are simple, detection time is short, and the detection results are stable. An anti-FMC63 ScFv antibody can reduce the cost of detecting universal anti-CD19 CAR-T cells.
    Type: Application
    Filed: November 25, 2020
    Publication date: January 26, 2023
    Inventors: Liang DA, Guowei WEI, Xin CHEN, Dongge FENG, Wei HE, Xuejun YU
  • Publication number: 20220277804
    Abstract: Systems and methods are described relating to a Poisson Boltzmann machine learning model, which may be executed to predict electrostatic solvation free energy for molecular compounds, such as proteins. Feature data input to the Poisson Boltzmann machine learning model may include multi-weighted colored subgraph centralities, which may be calculated based on edge definitions of pairwise atomic interactions between atoms of a given protein using a generalized exponential function and/or a generalized Lorentz function, either or both of which may be weighted based on atomic rigidity or atomic charge. Predictions of electrostatic solvation free energy performed by the Poisson Boltzmann machine learning model may be used as a basis for ranking candidate compounds for a defined target clinical application.
    Type: Application
    Filed: May 5, 2020
    Publication date: September 1, 2022
    Inventors: Guowei WEI, Zixuan CANG, Jiahui CHEN, Weihua GENG
  • Publication number: 20210027862
    Abstract: Characteristics of molecules and/or biomolecular complexes may be predicted using differential geometry based methods in combination with trained machine learning models. Element specific and element interactive manifolds may be constructed using element interactive number density and/or element interactive charge density to represent the atoms or the charges in selected element sets. Feature data may include element interactive curvatures of various types derived from element specific and element interactive manifolds at various scales. Element interactive curvatures computed from various element interactive manifolds may be input to trained machine learning models, which may be derived from corresponding machine learning algorithms.
    Type: Application
    Filed: April 1, 2019
    Publication date: January 28, 2021
    Inventors: Guowei Wei, Duc Nguyen, Zixuan Cang
  • Publication number: 20200354452
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, a chimeric antigen receptor or a bispecific antibody comprising a free immunoglobulin light chain VL, inter alia, useful for targeting and killing human mantel cell lymphoma (MCL) cells. Due to their ability to differentially bind MCL cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.
    Type: Application
    Filed: May 4, 2018
    Publication date: November 12, 2020
    Inventors: Hong Qin, Larry Kwak, Guowei Wei
  • Publication number: 20200071418
    Abstract: Provided herein are, inter alia, compositions and methods for the treatment of cancer. The compositions include, for example, an antibody variable domain or antibody construct, inter alia, useful for targeting and killing cancer cells. Due to their ability to differentially bind cancer cells versus non-cancer cells, the compositions provided herein may be used, for example, for therapeutic and diagnostic purposes.
    Type: Application
    Filed: May 4, 2018
    Publication date: March 5, 2020
    Inventors: Hong QIN, Larry W. KWAK, Guowei WEI
  • Publication number: 20190304568
    Abstract: Various characteristics of molecules and/or biomolecular complexes may be predicted using persistent homology and graph theory based methods in combination with trained machine learning algorithms. Feature data derived from one or more of element specific persistent homology barcodes, atom specific persistent homology barcodes, binned barcodes, multiscale weighted colored graphs, and/or evolutionary homology barcodes may be input to one or more trained machine learning models, which may be derived from one or more trained machine learning algorithms, such as gradient-boosted regression trees, deep neural networks, and/or convolutional neural networks.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 3, 2019
    Inventors: Guowei Wei, Duc Nguyen, Zixuan Cang